Advantages and future outlooks in the use of telemedicine in liver transplantation

doi:10.5500/wjt.v15.i3.104825

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (278)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

176

Sum=192

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=53

Sep 18, 2025 (publication date) through May 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Transplant. Sep 18, 2025; 15(3): 104825
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.104825

Advantages and future outlooks in the use of telemedicine in liver transplantation

Marco Zeppieri

Marco Zeppieri, Department of Ophthalmology, University Hospital of Udine, Udine 33100, Italy

Marco Zeppieri, Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127, Trieste, Italy

Author contributions: The sole author Zeppieri M completed all phases of the manuscript.

Conflict-of-interest statement: Dr. Zeppieri has nothing to disclose.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Marco Zeppieri, MD, PhD, Department of Ophthalmology, University Hospital of Udine, p. le S. Maria della Misericordia 15, Udine 33100, Italy. mark.zeppieri@asufc.sanita.fvg.it

Received: January 3, 2025
Revised: February 12, 2025
Accepted: February 19, 2025
Published online: September 18, 2025
Processing time: 105 Days and 21.9 Hours

Core Tip

Core Tip: The 2019 coronavirus pandemic shifted liver transplant (LT) evaluations (LTEs) to telemedicine. According to this study, telehealth did not affect LTE patients' likelihood of listing, waitlist mortality, or evaluation length. These data imply that LTEs can safely use telemedicine and that outcomes are comparable to in-person evaluations. These findings are important: Telehealth can improve access to LT services, especially since patients find it more convenient.